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Renal  glomeruli are an  important site for deposition of immune complexes that 
cause inflammation and subsequent  tissue damage. The glomerulus serves as a  size 
and charge barrier for circulating macromolecules and presents a  highly negatively 
charged (anionic) surface to the circulation (1). The role of the anionic charges on the 
binding,  formation,  and  persistance  of immune  complexes  in  glomeruli  has  only 
recently begun  to  be  examined.  Gallo  et  al.  (2)  showed  that  immune  complexes 
prepared with cationized antigen and cationized antigen alone bound to the anionic 
sites in the glomerular basement  membrane within  1 h  of administration, but later 
time  points  were  not  examined.  Oite et  al.  (3)  showed  the  binding  of cationized 
antigen  (Ab~.n)  1 to the glomerulus and the formation of subepithelial deposits when 
antibody was administered subsequent  to the binding of the antigen.  Furthermore, 
antibodies to DNA eluted from glomeruli of NZB/W and MRL/1  mice were more 
cationic than those in circulation (4), suggesting that cationic antibodies may prefer- 
entially lead to deposition of immune complexes in glomeruli. 
The proportion of naturally formed highly cationic antibodies is small and difficult 
to isolate in sufficient quantities to investigate their role in immune complex deposi- 
tion.  For  these  reasons,  chemical  cationization  of antibodies  was  performed  and 
antigen-binding ability was  preserved. Immune complexes prepared with  these ca- 
tionized antibodies (AgAbED)  demonstrated the important contribution of antibody 
charge to the glomerular deposition of immune complexes. The injected large-latticed 
AgAbED formed extensive subendothelial electron-dense deposits in mice. 
Materials and Methods 
Preparation of Antibodies and Antigen.  Rabbit  immunoglobulin G  (IgG)  was  purified from 
rabbit  fraction II  (Miles Laboratories, Elkhart,  IN)  by gel  filtration over Sephadex G-200 
column (Pharmacia Fine Chemicals,  Pharmacia Inc., Piscataway,  N  J). Rabbit antibodies to 
human serum albumin (HSA) were isolated by affinity chromatography, and the monomeric 
fractions  obtained by gel filtration were trace labeled with  125I, all  by previously  described 
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methods (5). HSA (E.R.  Squibb, New Brunswick, N  J)  was purified by DEAE ion exchange 
chromatography and gel filtration. 
Sucrose Density Gradient Analysis.  The monomeric status of the protein preparations and the 
size of immune complexes were  characterized  on  10-30%  sucrose in borate-buffered saline 
gradients,  run  37,000  rpm  at  4°C  for  16  h  in  a  SW41Ti  rotor  and  Beckman  L2-65B 
ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA). The samples were 
collected and analyzed for radioactivity on an automatic gamma counter (Searle Radiographics 
Inc., Des Plaines, IL). 
Cationization of the Antibody.  The reaction was carried out in a beaker in an ice bath. A typical 
experiment was as follows:  1.06 ml of ethylene diamine was added to 13.5 ml of 0.1 M sodium 
acetate buffer at pH 4.75, and the pH adjusted to 4.75 with concentrated HC1. The volume 
was brought to 20 ml with the same cold acetate buffer. The antibody preparation was added, 
7.0 mg/ml in 18-ml vol of acetate buffer. The pH was readjusted as needed to 4.75. 605 mg of 
EDAC, 1-ethyl-3-(3-dimethylamino-propyl)  carbodiimide HCI (Sigma Chemical Co., St. Louis, 
MO) was allowed to dissolve and the reaction maintained at pH 4.75 for 30 min. The unreacted 
reagents were removed by exhaustive dialysis against 0.2 M sodium borate buffer, 0.15 M NaC1, 
pH 8.0. 
The degree of substitution of ethylenediamine onto protein was assayed by spectrophoto- 
metric analysis for free amino groups using trinitrobenzenesulfonic  acid (TNBS). The TNBS 
method as  described by Habeeb  (6)  was modified by a  30-min incubation period at  room 
temperature in 10% sodium dodecyl sulfate before the addition of 1.0 M  HC1 to facilitate the 
solubilization of cationized proteins, which tended to precipitate during the assay. 
Isoelectric Focusing.  Isoelectric focusing was carried out on a flatbed Pharmacia apparatus. A 
stock solution was prepared by mixing 2.42 g acrylamide with 0.75 g bis-acrylamide (electro- 
phoretic grade; Bio-rad Laboratories, Richmond, CA) in 25 ml water and deionizing for  1 h 
with Amberlite ion exchange resin (Mallinckrodt Inc., St.  Louis, MO)  to remove the acrylic 
acid. To 15 ml of stock solution was added 1.9 ml ampholytes, pI range 3-10 (Pharmacia Fine 
Chemicals), 9.1 ml water, and 4 ml glycerol,  and the mixture was thoroughly degassed under 
vacuum.  The  gel  mold  was  flushed  with  nitrogen and  200  #1  of 22.8  mg/ml solution of 
ammonium persulfate, 30 #1 of TEMED (Biorad Laboratories) was added for polymerization 
and the gel was cast. Focusing was done at 20 W for 1.5 h at 15°C, and the gel was stained with 
Coomassie blue. The use of broad range  (pI  3-10)  standards  (Pharmacia Fine Chemicals) 
allowed direct determination of the pI from the gel. 
Preparation and Characterization of Immune Complexes.  Complexes were  prepared  at  fivefold 
antigen excess by weight  based  on equivalence points determined as  the  point where  free 
antigen and free antibody were at a minimum in sucrose  density gradient analysis. This was 
~150 #g of HSA/mg of antibody, which coincides with values obtained for unaltered anti- 
HSA determined by the precipitin reaction. Complexes were also prepared at 50-fold  antigen 
excess. All complexes were prepared at room temperature and equilibrated for 4-5 d at 4°C 
before use. Their size distribution did not change during storage at 4°C over a 3-mo period. 
Immunofluorescence.  Tissues were prepared for immunofluorescence and evaluation as previ- 
ously described  (8). Staining was  accomplished  with  one of the  following fluoresceinated 
antisera: goat antibodies to rabbit IgG (Kallestad Laboratories, Austin, TX), goat antibodies 
to mouse IgG (N. L. Cappel Laboratories, Cochranville, PA), goat antibodies to HSA (Kallestad 
Laboratories and N.  L  Cappel  Laboratories), goat  antibodies to mouse C3  (N.  L.  Cappel 
Laboratories). The specificity of the antisera was verified by use of purified rabbit IgG, mouse 
IgG, or HSA linked to agarose beads as previously described (9). The intensity of fluorescence 
was determined in a minimum of 10 glomeruli and graded 0-4+. Briefly, the standard grading 
system was as follows: 4+ glomeruli were readily visible at 40 X magnification,  and fluorescence 
was present throughout each glomerulus; 3+ were slightly visible at 40 ×, and fluorescence was 
present in all quadrants of glomeruli; 2+ glomeruli were visible at 100 X and contained partial 
staining in 2-3 quadrants;  1+  glomeruli were dimly visible at  100 X or contained isolated 
deposits;  and trace positive glomeruli were visible only at 400 X or contained deposits in <20% 
of the 10 or more glomeruli examined. In some experiments substantially heavier deposits were 
observed and differentiation between levels of 4+ staining was not possible with the defined 
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tography was  performed  on  a  Zeiss  epifluorescent  microscope  (Zeiss,  Oberkochen,  Federal 
Republic of Germany) with TriX Pan ASA 400 film (Eastman Kodak, Rochester, NY) with a 
20-s exposure time. 
Electron Microscopy.  Samples  of renal  cortex  were  prepared  for electron  microscopy and 
processed as previously described (8). 
Experimental Design.  Female  C57BI/6J  mice  were  used  (The  Jackson  Laboratory,  Bar 
Harbor, ME)  and ranged in size from  18-22 g.  Mice received KI in their drinking water at 
least  24 h before injection and throughout the experiment. All tail vein injections consisted of 
0.5 ml of 0.2 M borate, 0.15 M  NaCI, pH 8.0 buffer containing the designated protein. 
For blood clearance kinetics,  either 1 mg 12~I-AbED  or Ag125I-Ab~D  at fivefold antigen excess 
and containing 1 mg of a25I-AbED  was injected. Retroorbital plexus blood samples of 10 ~1 were 
drawn  at  1, 2, 4,  6,  10,  15, and  30  min,  1, 2,  4,  8,  12,  24,  48,  72, and  96 h.  Samples were 
solubilized in 1 ml 0.1 M HC1 and precipitated by the addition of 0.5 ml 22.5% trichloroacetic 
acid (TCA). After centrifugation, the pellet and supernatant  were separated and assayed for 
radioactivity.  Only  TCA-precipitable  material  was  considered  to  represent  intact  protein 
remaining in  circulation.  The percentage  remaining  in circulation  was calculated  from the 
amount injected and the blood volume of the mouse calculated from the relationship of 0.08 
ml/g of body weight as previously determined  (10). This  method of analysis was necessary 
because of the removal of large fractions of the injected dose before the 1-min time point. Data 
for clearance of unaltered antibody and complexes prepared with unaltered antibodies have 
been previously described  (11). Analysis of blood clearance curves was achieved by graphic 
subtraction of terminal components as previously described (12). 
For glomerular localization studies, varying doses of unaltered antibodies, cationized anti- 
bodies, or immune complexes with one or the other antibody preparations were administered. 
Mice were killed  at  1 min,  1, 12, 48, and 72 h, and  14 d after injection. 
For glomerular localization of AgAbED made at  50-fold antigen  excess,  a  l-rag dose was 
administered,  and mice were killed at  1 min,  1,  12, and  72 h  after injection.  To determine 
removal of complexes from glomeruli by excess  antigen,  four mice were injected with  1 mg 
AgAbED made at fivefold antigen excess. 12 h later, each received 10 mg of liSA intravenously. 
The mice were killed at 24, 36, 48, and 72 h after the injection of AgAbED. 
Results 
Characterization of Cationized Antibodies and Immune  Complexes.  The average number 
of modified  amino  groups  in  the  anti-HSA  ranged  from  27  to  35.  On  isoelectric 
focusing these preparations  exhibited  a  pI >--9.3. Only small amounts of unaltered or 
minimally altered IgG persisted  (Fig.  1). AbED readily precipitated with antigen and 
exhibited  specificity for HSA.  In the cationized  anti-HSA,  however,  21-25%  of the 
antibody remained monomeric in antigen excess on sucrose density gradient analysis 
(Fig.  2),  whereas  only  10%  of unaltered  anti-HSA remained  in  this  fraction.  Thus, 
11-15% of antibodies had been altered sufficiently to lose reactivity with antigen. 
To determine if alterations other than the cationization could have contributed to 
the changes to be described, rabbit IgG was substituted  with glycine by the carbodi- 
imide procedure. In this manner, an average of 18.5 glycines were substituted per IgG 
molecule as determined  by amino acid analysis  (AAA Laboratories,  Mercer  Island, 
WA).  With  this  substitution,  the  number  of charged  groups on  IgG would  not  be 
altered,  and  in  fact  the  pattern  of IgG on isoelectrofocusing was not  changed.  The 
clearance from circulation of the radiolabeled, glycine-substituted IgG was not altered 
in comparison to native IgG, and no glomerular localization was found by immuno- 
fluorescence microscopy (data not shown). 
Clearance Kinetics of AbED and AgAbED.  The blood clearance kinetics of AbED were 
carried  out  to determine  if the  cationization  substantially  altered  the  fate  of these 
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Fro.  1.  Isoelectric focusing pattern of unaltered and cationized antibodies. In lane a, The unaltered 
anti-HSA shows the polydispersed pattern characteristic for polyclonal IgG. Lanes b  and d  show 
the standards. In lane c, The majority of AbED had a pI _~ 9.3, with only a small amount of materlal 
exhibiting lower pI. 
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FZG.  2.  Sucrose density gradient ultracentrifugation patterns of Ag1251-AbED. (A) Complexes were 
prepared at fivefold  antigen excess and show 21% of the labeled antibody as unreacted monomer. 
(B) Immune complexes were prepared with the same AbED at 50-fold  antigen excess. The complexes 
prepared at 50-fold  antigen excess are smaller than those prepared at fivefold antigen excess and are 
composed primarily of Ag2Ab2 and AglAba, as previously described (7). 
lzSI-AbED was followed for a 96-h period. By 1 min after injection, only 53.9% -+ 3.7% 
of the injected  material remained  in  circulation.  The subsequent  removal was best 
characterized by three exponential components. The terminal component accounted 
for 7.85%  of the injected  material and possessed a  t½ of 77.4 h,  the same tl/2 as the 
terminal component of unaltered  anti-HSA  (Fig.  3),  and  may represent  only mini- 
mally cationized anti-HSA. The appearance of 125I-labeled  TCA-soluble material in 
circulation  30  min after injection  of lzsI-AbED  indicated  degradation  of the  rapidly 
removed ABED. A similar burst of TCA-soluble radioactivity was not observed at any 770  CATIONIZED ANTIBODIES  IN IMMUNE COMPLEXES  IN GLOMERULI 
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Fro.  3.  Blood  clearance kinetics of AbED and AgAbED.  The mean TCA-precipitable radioactivity 
on the antibodies was determined for three mice, and the curves were fitted by linear regression 
analysis. The clearance of AbED alone (O) is accelerated as compared with unaltered antibody (Ab) 
(- - -), but the final components are parallel suggesting a small percentage of unmodified or lightly 
modified Ab in ABED. The clearance of AgAbED  at fivefold antigen excess (O) is also substantially 
accelerated as compared with immune complexes prepared with unaltered Ab (  ). 
time point after the injection of unaltered antibody. Liver and kidney binding of 12~I- 
labeled material reached a maximum  1 h after injection and was 21.4% of the injected 
dose in the liver and  19.6% in the kidneys. 
The blood clearance  kinetics  of AgAbED were examined  in  a  similar  manner  by 
injection  of complexes  prepared  at  fivefold  antigen  excess  with  1  mg  125I-AbED 
contained  in  the dose.  By  1 min after  injection,  only 38.8%  +  2.3%  of the material 
remained  in circulation. The subsequent  removal of radioactivity was best described 
by three exponential components. The terminal component accounted for removal of 
4.35% of the injected  dose and had a  t½ of 34.0 h  (Fig.  3).  This slow removal phase 
was comparable to that  previously established  for removal of similar  immune com- 
plexes prepared with unaltered  anti-HSA (11). The appearance of 125I-labeled TCA- 
soluble  material  in  circulation  30  min  after  injection  of Ag125I-AbED indicated  the 
degradation  of the  rapidly  removed  125I-AbED in  the  complexes.  Liver  and  kidney 
binding of 125I-labeled material reached a maximum 1 h after injection and was 28.3% 
of the  injected  dose  in  the  liver  and  only  3.4%  present  in  the  kidneys.  The  slow 
removal of a portion of the injected complexes suggested that these were small-latticed 
complexes containing minimally cationized antibodies. To assure that the removal of 
immune complexes did  not  represent  pooling of complexes in extravascular  spaces, 
total  body  disappearance  was  determined.  The  data  points  at  72  and  96  h  after 
injection of AgAbED showed that the total body disappearance curve was parallel  to 
the  slow  exponential  component  of clearance  from  the  blood.  At  96  h,  6%  of the 
injected  125I remained  in  the  body  and  0.6%  remained  in  the  circulation,  thus 
providing  no  evidence  for  an  unusually  large  reservoir  of complexes  containing 
cationized  antibodies.  The disappearance  from circulation  of AgAbED with  a  5-rag 
dose of antibodies was identical to that of the  1-mg dose. 
Glomerular Localization Studies.  In initial experiments, the renal localization of AbED 
alone was examined by injection of 5 and 1 mg doses of AbED, which were comparable 
to the largest doses administered  as immune complexes (Table I). By 1 min, extensive 
deposition of AbED was already noted  (Fig. 4 a). This high level of staining for rabbit V. JOYCE  GAUTHIER, MART  MANNIK,  AND GARY  E.  STRIKER 
TABLE  I 
Antibody dose 
Ab  AbFa)  AgAb  AgAbED  Time 
5.0  5.0  1.0  5.0  5.0  1.0  0.5  0.05 
mg 
1 min  0  4+  4+  1+  4+  4+  4+  4+ 
l h  0  4+  4+  I+  4+  4+  4+  3+ 
12h  0  2+  1+  2+  4+  4+  4+  2+ 
48 h  0  0  0  1+  4+  4+  3+  1+ 
72h  0  0  0  1+  4+  4+  3+  1+ 
14 d  0  0  0  0-tr*  4+  4+  3+  tr 
Glomerular staining for rabbit IgG after administration of either normal or 
cationized antibodies alone or as  immune complexes was  evaluated on  a 
scale of 0-4+ staining. 
* Trace positive glomeruli. 
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Fro.  4.  Glomerular immunofluorescence patterns after staining with fluoresceinated antibody to 
rabbit IgG. The glomeruli of mice injected with 5 mg of AbED alone stain intensely at 1 min (a) but 
only minimally by  12 h  (b)  after injection.  At  72 h  (c)  and  14 d  (d),  the glomeruli are negative. 
When the AgAb~.n  containing 5 mg of AbED was administered, the glomeruli stain extensively at all 
time points. Staining is predominantly of peripheral loop patterns at 1 min (e) and 12 h (f), whereas 
at 72 h (g) and  14 d 0a), mesangial staining is present  as well. 
IgG persisted  through  1 h, decreased  by  12 h  (Fig. 4b),  and had  disappeared  by  72 h 
after injection (Fig. 4c-d).  The staining for rabbit  IgG was extensive and primarily in 
a  loop pattern.  Controls with unaltered  antibody  showed  no glomerular  localization 
at  any time point. 
Administration  of  AbED  resulted  in  specific  immunofluorescence  in  the  tubules 
from  1  min  to  72  h.  At  1  min,  AbED could  be  detected  in  the  lumen  and  proximal 
tubule  brush  border,  whereas  by  1  h,  the  staining  of the  cortex  was  extensive  and 
obliterated  all  structural  detail.  This  maximal  staining  of  the  renal  cortex  corre- 
sponded  with the maximal  uptake  of 125I-AbED by the kidney as described  above.  By 
12 h, the strongest  staining persisted  in the base of the tubular  cells, and  some degree 
of staining in this region persisted  at  72  h  but was absent  by  14 d. 772  CATIONIZED  ANTIBODIES IN IMMUNE COMPLEXES IN GLOMERULI 
Significant glomerular staining for mouse C3 or mouse IgG was not detected until 
after 72 h. At later time points, deposition of these materials could be expected from 
an endogenous immune response to the injected protein. 
Electron  microscopy of animals  receiving the  5-mg  dose  of AbED  revealed  fine 
electron dense deposits at the anionic sites in the lamina rara interna and lamina rara 
externa of the basement membrane at the  1 min  (Fig. 5 a) and  1 h  time points (not 
shown). At 12 and 72 h  (Figure 5 b, c), small spherical deposits were seen occasionally 
in the subendothelial regions. By 14 d the basement membrane area lacked any sign 
of deposits  (Figure 5d), but mesangial deposits were present despite the absence of 
positive immunofluoreseence. 
After the injection of the AgAbED, made at fivefold antigen excess, both rabbit IgG 
and HSA were detected by immunofluorescence microscopy in the glomeruli at 1 min 
(Fig.  4e). Such deposits persisted through  14 days (Fig. 4 f-h). At dose levels of 5,  1, 
and 0.5 mg of antibody in AgAbEo, this localization was extensive. When the dose 
was decreased to 0.05  mg, the initial deposits were 4-1- and decreased at later time 
points  (Table I).  In comparison tO the localization observed after AbED alone, the 
immune complex deposits containing AbED persisted longer (Table I). The patterns 
of immunofluorescence represented  capillary loop deposition  through  72  h  with  a 
granular pattern apparent in the 72-h animals. Mesangial deposition was prominent 
at 14 d with a residual loop pattern as well. Mouse C3 was not found by 72 h, but was 
present  on  the  14th  d.  Mouse  IgG  was  found  in  large  amounts  on  the  14th  d, 
indicative of an endogenous immune response to the injected immune complexes. 
Unlike the results obtained with free ABED, tubular localization of antibody was 
not detected from 1 min to 12 h after the injection of AgAbEo. After 12 h and through 
14 d, small punctate deposits of antigen and antibody were seen in some tubules. 
Electron microscopy of the glomeruli obtained 1 min after the 5-rag dose of AgAbeD 
revealed some dense deposits at the anionic sites in the glomerular basement mem- 
brane  (Fig.  5 e). This pattern persisted at  the  1-h  time point  (not shown)  with the 
appearance of a few formed deposits in the subendothelial areas. By 12 h, the anionic 
sites  no  longer  contained  deposits  and  larger  dense  subendothelial  deposits  were 
present (Fig. 5 f). At 72 h the subendothelial deposits were numerous and dense (Fig. 
5 g). Small subepithelial deposits were present in some sections from 12 to 72 h. By 14 
d the subendothelial deposits were absent and small, dense, well-defined subepithelial 
deposits were present (Fig. 5 h). Mesangial deposits were noted in samples from 12 h 
to 14 d with massive amounts present in the 14-d specimen. 
Role of Lattice in Glomerular Deposition of AgAbEo.  Previous studies  (13) have shown 
that small-latticed immune complexes prepared at large antigen excess do not deposit 
in glomeruli. To investigate the role of lattice on patterns of deposition and persistence 
of AgAbED, immune complexes were prepared at 50-fold antigen excess and confirmed 
to be of small lattice by sucrose density gradient analysis (Fig. 2 B). After injection of 
1 mg of AbED in immune complexes, initial deposits were noted in glomeruli as above, 
but by 12 h only sparse deposits remained (Fig. 6). Thus, the time course of removal 
from the glomeruli of AgAbED at 50-fold antigen excess was similar to the deposition 
and removal of AbED alone. After the injection of the small-latticed AgAbED,  HSA 
could also be detected in the glomeruli, indicating that the deposition was of immune 
complexes and not antibody alone. 
The ability to release deposited AgAbED  from glomeruli with excess antigen  has V.  JOYCE  GAUTHIER,  MART  MANNIK,  AND  GARY  E.  STRIKER  773 
Fro.  5.  Electron micrographs of glomerular capillaries. After a  5-mg dose of ABED, electron-dense 
deposits are visible at the anionic sites in the lamina rara externa and lamina rara interna (arrows) 
at  1 rain (a). Round deposits (arrow)  are seen in the subendothelial region at  12 h  (b). By 72 h  (c), 
occasional round deposits (arrow)  are still present, and by  14 d  (d),  the ultrastructure is normal. 
After administration of AgAbv~ containing 5 mg of AbgD, deposits are present at the anionic sites 
at  1  min  (e),  and  in  the  subendothelial  area  at  12  h  (f)  and  72  h  (g)  (arrows).  Occasional 
subepithelial deposits (arrowheads) are visible at  72 h  (g). By  14 d  (h), large subepithelial deposits 
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FIG.  6.  Immunofluorescence patterns after staining with  fluoresceinated anti-rabbit  IgG.  After 
injection of 1 mg of AgAbED prepared at fivefold antigen excess, the glomeruli stain intensely at  1 
min (a),  12 h  (b), and 72 h  (c). After injection of a  l-rag dose of small-latticed AgAblm prepared at 
50-fold antigen excess, the glomeruli stain intensely at  i  min (d), but by  12 h  (e) and 72 h  (f), the 
glomeruli are negative. Staining for the presence of antigen yielded similar patterns. These results 
indicate that small-latticed AgAb~aj localized but did not persist in the renal glomeruli. 
been  previously described  (14).  In similarly designed  experiments,  a  10-mg dose of 
HSA was administered  12 h after the injection of a  1-mg dose of AgAbED prepared at 
fivefold antigen excess. The intensity of immunofluorescence for rabbit  IgG at  72  h 
was 2-t- after the administration  of excess HSA, compared with  4-1- in control mice 
receiving the  dose of AgAbED but  not  the  HSA. Thus,  the  release of the  deposited 
AgAbED from glomeruli was incomplete with the administration of excess antigen. 
Discussion 
With the methods used, extensive cationization of antibodies was achieved and the 
altered  antibodies  retained  the  capacity  to  form  soluble  immune  complexes  and 
immune precipitates. Up to  15% of the modified antibodies, however, lost the ability 
to combine with the antigen.  Furthermore, the described alterations of the fate and 
glomerular  localization  of antibodies  alone  was  attributable  to  the  change  in  the 
isoelectric point  and  not  due  to other chemical alterations,  as  the  substitution  of a 
neutral amino acid by the same method causes neither increased disappearance from 
circulation nor glomerular localization of the modified antibodies. 
The blood disappearance kinetics of AbED and AgAbED were significantly acceler- 
ated over those seen with unaltered antibodies and immune complexes of comparable 
size.  The  very rapid  initial  clearance  of AbED  before  1 rain  may  be  due  to  their 
adsorption to the negatively charged surfaces exposed to the circulation such as the 
endothelium, formed elements of the blood, and the glomerular basement membrane. 
The subsequent clearance could be attributable in part to glomerular filtration of the 
AbED as evidenced by the appearance of material in the proximal tubule lumen at  1 
rain and the subsequent progressive penetrance into the tubular cells. Hepatic uptake 
also contributed to removal of AbED and AgAbED, but the mechanism for this was not 
elucidated. 
Glomerular deposition of AbED alone was extensive and extremely rapid, but these V. JOYCE GAUTHIER, MART MANNIK, AND GARY E. STRIKER  775 
deposits only persisted until  ~12 h, a  time point at which the AbED were removed 
from circulation. These deposits were primarily at the anionic sites in the lamina rara 
interna and lamina rara externa of the glomerular basement membrane at the 1-min 
and  1-h times. 
When  AbED  were  administered  in  the  form  of immune  complexes,  extensive 
glomerular depo.~ition of antibodies and antigen, which persisted through  14 d, was 
shown by immunofluorescence. Even though both antigen and antibody were present 
in similar locations by immunofluorescent microscopy, the presence of some free AbED 
alone  in  the  observed electron-dense deposits  cannot  be excluded.  By  12  h,  large 
deposits were evident in the subendothelial area throughout the glomerular capillary 
loop.  This  finding  was  in  contrast  to  the  deposition  of immune  complexes with 
unaltered antibodies, which were found mainly in the subendothelial area adjacent to 
the mesangium and in the mesangial matrix (8). Furthermore, the extensive suben- 
dothelial deposits persisted at  72 h. Electron-dense deposits were also present in the 
mesangial  matrix  from  12  to  72  h.  By immunofluorescence microscopy, extensive 
glomerular deposits developed even with a  0.05-mg dose of the AgAbED,  indicating 
the propensity of the altered antibodies in immune complexes to localize in glomeruli. 
The observations that both AbED alone and AgAbED initially bound to the fixed 
negative charges in the glomerular basement membrane, but only immune complexes 
formed extensive subendothelial deposits along the loop of the capillary wall, suggests 
a sequence of events in the deposition of immune complexes in this location. Both of 
these materials bound only transiently to the anionic sites in the lamina rarae of the 
basement membrane and were released from these sites by as yet unknown mecha- 
nisms. The immune complexes, however, thereafter formed large deposits in suben- 
dothelial areas, presumably due to their ability to rearrange to form large lattices that 
then  remained  in  the subendothelial  location.  The  described experiments did  not 
distinguish  whether  the  complexes  that  evolved in  the  subendothelial  areas  were 
formed from the initially deposited material  from the lamina tara externa, lamina 
rara interna, or both. It is unlikely that the subendothelial deposits developed from 
complexes still  in circulation, since the bulk of the complexes (90%)  was no longer 
present in circulation at 1 h, when only few subendothelial deposits were noted. Thus, 
the sequence of observed deposits supports the hypothesis that indeed the extensive 
subendothelial deposits evolved from the complexes that had initially bound to the 
fixed negative charges in or at the basement membrane. The subsequent fate of the 
subendothelial immune complexes was not delineated. 
The recorded observations 14 d after the injection of AgAbED showed that both the 
antigen and antibody were still present. In addition, large quantities of mouse IgG 
and mouse C3 were also present, indicative of the endogenous immune response to 
the  injected  antigen,  antibody,  or  both.  At  this  long  interval,  the  electron-dense 
deposits were both in subepithetial and mesangial areas, and not in the subendothelial 
area.  The  subepithelial  deposits  at  this  time  may  well  have  developed by  in  situ 
formation  of immune  complexes, consisting of mouse  antibodies  and  the  injected 
HSA, rabbit anti-HSA, or both as antigens. It is of interest that the prior deposition 
of cationized antigen in the glomerular basement membrane, followed by antibody 
injection,  resulted  in  subepithelial  deposits  with  no  mesangial  or  subendothelial 
deposits  (3).  The  mesangial  deposits  noted  at  14  d  may  have  arisen  from  the 
subendothelial deposits after the endogenous immune response, but direct mesangial 776  CATIONIZED  ANTIBODIES IN IMMUNE COMPLEXES IN GLOMERULI 
deposition of residual circulating HSA and  rabbit  anti-HSA by newly synthesized 
mouse antibodies cannot be ruled out. The presence of extensive rabbit IgG, however, 
supports the possibility that subendothelial deposits evolved into mesangial deposits, 
because at  96 h  only 0.6  +  0.1%  of the radiolabel was  present  in circulation, and 
would have contributed little to mesangial deposition by endogenous immune clear- 
ance. 
The absence of mouse C3 deposits in glomeruli up to 72 h after injection of AgAbED 
suggested that these antibodies were inefficient in the activation of complement. This 
was confirmed in vitro by the failure of these complexes to activate human comple- 
ment (unpublished observation). 
Previous studies showed that  only large-latticed, preformed, circulating immune 
complexes deposited in renal glomcruli (8,  13). AgAbED prepared at 50-fold antigen 
excess, consisting of small-latticed  (Ag2Ab~ and  AglAbl)  complexes, deposited and 
persisted  in  glomeruli  comparable  to  the  AbED alone.  This  observation  could  be 
explained  by the  hypothesis that  immune  complexes capable  of cross-linking  into 
larger deposits wcrc necessary for the persistence in glomeruli. The already deposited 
complexes in the glomeruli wcrc incompletely removed by the administration of excess 
antigen,  in  contrast  to the complctc rclcasc of complexes prepared with  unaltered 
antibodies  (14).  This finding indicated  that  the charge of antibodies  in  complexes 
contributed to their rctcntion and persistence in the glomcruli. 
This study demonstrated the role of antibody charge in glomcrular localization of 
immune complexes. The net charge of an immune complex as a whole is undoubtedly 
the most important paramctcr in this localization. Immune complex net charge will 
depend on the charge of the antibody and antigen  and  the nature of their union, 
rather than thc simple arithmetic net charge of the complex. In the results herein, the 
antibodies wcrc cationized and then combined with HSA, an anionic protein. The 
resulting complexes bound to anionic sites in glomeruli, forming extensive subendo- 
thelial  deposits  that  persisted.  In  the work of Ebling and  Hahn  (4), cationic anti- 
DNA antibodies were eluted from NZB/W and MRL/1 kidneys, thus supporting the 
hypothesis that charge plays an important role in the in vivo localization, formation, 
and persistence of immune complex deposits in glomcruli. 
Summary 
To study the  interaction of positively charged antibodies  in  immune complexes 
with the fixed negative charge on the glomerular capillary wall, chemical cationization 
of antibody was  accomplished  with  the  maintenance  of antigen-binding  activity. 
These cationized antibodies bound rapidly to glomeruli but  did not persist.  Large- 
latticed  immune  complexes  formed  with  these  cationic  antibodies  showed  rapid 
deposition and persistence in renal glomeruli, even when administered in small doses. 
Electron-dense deposits were present at the anionic sites in the glomerular basement 
membrane at  1 min and  1 h, with extensive subendothelial deposits present from 12 
to 72 h. By 14 d, the deposits were seen in the subepithelial region and the glomerular 
mesangium. The administration of small-latticed immune complexes prepared with 
cationized antibody revealed initial deposition without persistence in glomeruli in a 
manner similar to cationized antibodies alone. Thus, the positive charges on antibodies 
in immune complexes contribute to the deposition and persistence of the complexes V. JOYCE  GAUTHIER, MART MANNIK, AND GARY E.  STRIKER 
in glomeruli, particularly in the subendothelial area. 
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